In addition, pathway analysis and in vivo validation experiment showed that modulation of fibrosis (the top1 enriched pathway), energy metabolism, and inflammation pathways may be the main mechanisms of STDP against CHF, and inhibition of ERK/MAPK and TGF-β signaling is the specific molecular events. This evidence concerns the gene TGFB1 and congestive heart failure.